Recap: Rite Aid Q4 Earnings

 

Shares of Rite Aid RAD fell 0.4% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 110.81% year over year to ($0.78), which missed the estimate of ($0.76).

Revenue of $5,917,000,000 higher by 3.32% year over year, which beat the estimate of $5,800,000,000.

Outlook

Rite Aid said it sees Q1 sales of $6.1 billiob to $6.3 billion.

Conference Call Details

Date: Apr 15, 2021

Time: 08:30 AM

ET Webcast URL: https://www.riteaid.com/corporate/investor-relations/presentations

Recent Stock Performance

52-week high: $32.48

52-week low: $8.86

Price action over last quarter: Up 1.77%

Company Overview

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!